Bracco Suisse S.A., is part of Bracco Imaging S.p.a, one of the world’s leading companies in the diagnostic imaging business.
Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs, for all key diagnostic imaging modalities: X-ray Imaging (including Computed Tomography-CT, Interventional Radiology, and Cardiac Catheterization), Magnetic Resonance Imaging (MRI), Contrast Enhanced Ultrasound (CEUS) and Gastrointestinal Endoscopy. The diagnostic imaging offer is completed by several medical devices and advanced administration systems for contrast imaging products in the fields of radiology.
The Company operates in more than 100 markets worldwide, either directly or indirectly, through subsidiaries, joint ventures, licenses and distribution partnership agreements. Bracco Imaging has a strong presence in key geographies: North America, Europe and Japan operating through the Joint Venture Bracco-Eisai Co. Ltd. The Company also operates in Brazil, South Korea, and China through the Joint Venture Bracco Sine Pharmaceutical Corp. Ltd.
Manufacturing activities are located in Italy, Switzerland, Japan, China, and Germany while R&D activities are managed in Italy, Switzerland, and USA.
Via Ponteggia 23
|T.: +41 91 611 53 10|
|F.: +41 91 611 53 11|
Main activities Licensing-In ● Licensing-Out ● Trading ●
Drug stages Registration ● Market ● Life cycle management ●
Therapeutic areas Cardiology ● Cardiovascular ● CNS ● Gastrointestinal ● Other ●
Markets CH ● EU Top 5 ● Rest of Europe ● USA and Canada ● LATAM ● MENA ● BRICS ● ASEAN ● Africa ○ Australia ● Brazil ● China ● India ● Japan ● Korea ● Other ●
Drug product forms Injectable ● Oral (solid) ● Oral (liquid) ● Other ●
Other activities (non pharma) Distribution ● Medical Devices ●